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Previewspressing question pertains to how the
dynamic control of vessel diameter is
sensed and regulated. Blood vessels
are remarkable structures with the
strength to absorb pressure and the flex-
ibility to adapt to homeostatic needs.
Unraveling the operative molecular web
that coordinates alterations in vessel
diameter will clearly be our next chal-
lenge in understanding vascular
development.414 Developmental Cell 20, April 19, 2011 ª2REFERENCES
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iRhoms are inactive rhomboid-like pseudoproteases that lack essential catalytic residues. Although iRhoms
are highly conserved in metazoan species, little is known about their function. In a recent issue of Cell, Zettl
et al. (2011) show that iRhoms regulate growth factor signaling through endoplasmic reticulum-associated
protein degradation (ERAD).Highly conserved among all sequenced
metazoans, iRhoms are related to rhom-
boid intramembrane serine proteases,
but are not active proteases, as they
lack the essential catalytic residues
required for serine proteases and have
no proteolytic activity. Although their
high degree of conservation between
organisms suggests that these pseudo-
proteases are under evolutionary selec-
tive pressure, their functional significance
is largely unknown. A previous study re-
ported that human iRhom1 interacts with
the human epidermal growth factor
(EGF) when it is overexpressed in
Drosophila, suggesting a possible link
between an iRhom and EGFR signaling
in mammals (Freeman, 2008). In a recent
issue of Cell, Zettl et al. (2011) show in
both Drosophila and mammalian cells
that iRhoms regulate growth factor
signaling (e.g., EGFR pathways) through
the ER quality control machinery that
function in endoplasmic reticulum-asso-ciated protein degradation (ERAD)
(Figure 1).
About one third of the eukaryotic ge-
nome encodes membrane and secretory
proteins, most of which undergo folding
and modification in the ER. Protein folding
is the most error-prone process in gene
expression. When ER homeostasis is dis-
rupted, or when cells are stimulated to
secrete large amounts of protein, unfolded
and misfolded proteins accumulate in the
ER and activate the unfolded protein
response (UPR). The UPR is a group of
adaptive signaling pathways that increase
the capacity for ER protein folding, at-
tenuate global mRNA translation, and
enhance protein degradation through
the transcriptional induction of the ERAD
machinery (Ron andWalter, 2007). Eukary-
otic cells have evolved a robust ER quality
control system that recognizes correctly
folded proteins for trafficking to the Golgi
compartment. In contrast, unfolded and
misfolded proteins are retained in the ERfor chaperone-assisted refolding. If mis-
folding persists, proteins are targeted to
the ERAD pathway, which requires retro-
translocation from theER to the cytoplasm,
where they are polyubiquitylated and
degraded by the proteasome (Hebert
et al., 2010).
In this study, Zettl et al. (2011) first
confirmed previous results by showing
that Drosophila, murine, and human
iRhoms are catalytically inert against a
variety of rhomboid substrates, including
Drosophila EGFR ligands and murine
EGF.Unlike the active rhomboidproteases
that reside in the Golgi and plasma
membrane, the iRhoms localize to the ER.
To reveal the function of iRhoms, Zettl
et al. (2011) then applied Drosophila
genetics. In Drosophila embryos, larvae,
and adults, iRhom RNA is enriched in
neuronal cells, suggesting that iRhoms
may act in the development and/or func-
tion of the nervous system. The authors
generated a Drosophila null mutant of
Figure 1. iRhoms Regulate EGF Secretion through ERAD
The secretion of EGF family ligands is constitutively regulated by ER transmembrane pseudoproteases
called iRhoms. (Top) After folding and post-translational modification in the ER, EGF can bind to iRhom
on the ER membrane, which targets EGF to the ERAD machinery for degradation. This process requires
the ERAD components EDEM2 and HRD1 and the 26S proteasome. (Bottom) Alternatively, EGF is pack-
aged in COPII vesicles for trafficking to the Golgi apparatus, where it is cleaved by rhomboid proteases
and released from the cell.
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PreviewsiRhom that had no discernible defects dur-
ing development, although themutant flies
displayed a severe decrease in their day-
time activity (referred to as a ‘‘sleep’’-like
state). This result was confirmed by neu-
ron-specific transgene rescue of iRhom
in the mutant flies. Given the established
relationship among rhomboid proteases
in the central nervous system, activation
of EGFR signaling, and the sleep-like
phenotype in Drosophila (Foltenyi et al.,
2007), the authors dissected how iRhoms
affect EGFR pathways by analyzing
genetic interactions. They found that the
rough eye phenotype inDrosophila caused
by EGFR hyperactivation through Rhom-
boid-1overexpression inversely correlated
with the expression level of iRhom.
Additionally, a reduction in EGFR sig-
naling reversed the sleep-like phenotype
in iRhom mutant flies. No genetic in-
teractions were identified between iRhom
and other developmentally significant
pathways, including Wnt, Notch, Hed-
gehog, and Dpp. These results, together
with other synergistic genetic interactions,supported a specific role for Drosophila
iRhom in the inhibition of EGFR signaling.
To delineate the mechanism of how
Drosophila iRhom inhibits EGFR sig-
naling, the authors first examined whether
iRhoms inhibit Rhomboid-1 activity in cell
culture. The cleavage and release of
Drosophila EGFR ligands by Drosophila
Rhomboid-1 in COS7 cells was inhibited
by coexpression of Drosophila iRhom.
Human and murine iRhoms also inhibited
cleavage and release of murine EGF. In
addition, the release of a metalloprotease
substrate was not affected by iRhom,
demonstrating the specificity of this pseu-
doprotease in inhibiting Rhomboids. The
authors further showed that iRhoms still
inhibit the release of EGF in cells that do
not harbor Rhomboid activity, suggesting
that iRhoms act on Rhomboid substrates
rather than by inhibiting Rhomboid
activity. In support of this, iRhoms act on
mutant EGF molecules that are not direct
targets of active rhomboid proteases.
The authors then demonstrated that
iRhom-induced downregulation of EGFDevelopmental Celrequires proteasome activity. Given that
ER-localized EGF needs to be extracted
from the ER to the cytoplasm for degrada-
tion by the proteasome and that iRhoms
localize and function in the ER, the
authors tested whether iRhoms regulate
EGF family ligands through ERAD. They
showed that EGF coimmunoprecipitates
with murine and human iRhoms. In addi-
tion, pulse-chase analysis examining the
intracellular kinetics of EGF upon protea-
some inhibition showed slowed EGF
secretion when iRhom is coexpressed,
further supporting direct binding of intra-
cellular EGF to iRhoms. Finally, the
authors showed that knockdown of
ERAD components Hrd1 and Edem2
abolished the inhibition of EGFR signaling
upon overexpression of EGFR inhibitors,
demonstrating that ERAD downregulates
EGFR signaling under normal conditions.
ERAD is not restricted to misfolded/
unfolded proteins under conditions of ER
stress, but also operates on short-lived
ER proteins and proteins with regulated
half-lives, such as HMG-CoA reductase,
a rate-limiting enzyme in cholesterol
metabolism (Brodsky and Wojcikiewicz,
2009). A recent study also suggested that
Hedgehog ligand is constitutively
degraded by ERAD after self-cleavage
in the ER (Chen et al., 2011). The findings
of Zettl et al. (2011) now provide additional
insight into the function of ERAD in the
regulation of intracellular signaling by
showing that iRhoms downregulate EGF
family ligands by targeting them to the
ERAD machinery. The study also provides
evidence that transmembrane pseudopro-
teases play an important role in ER quality
control. There do remain a number of
questions. The finding that iRhoms can
act on proteins that are not substrates of
active rhomboids leads to the question of
how iRhoms actually recognize their
targets. Since ERAD has specifically
evolved to target proteins with altered
conformations to degradation, is EGF
unfolding or misfolding part of the iRhom
recognition event? In addition, the precise
mechanism by which iRhoms orchestrate
ERAD of EGF family ligands is unknown.
To elucidate this process, it would be
helpful to define what ERAD components
displayphysical and functional interactions
with iRhoms. Do iRhoms simply act
as adaptor molecules to assemble sub-
strates with the ERAD machinery, or do
they actively participate in this process?l 20, April 19, 2011 ª2011 Elsevier Inc. 415
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PreviewsiRhom-dependent degradation of EGF
requires two components of the
ERAD machinery: EDEM2 and HRD1.
EDEMs (ER-degradation enhancing
a-mannosidase-like protein) belong to the
a1,2-mannosidase family that are
proposed to accelerate ERAD, possibly
through cleavage of mannose residues on
asparagine(N)-linked glycans (Hebert
et al., 2010). Are N-glycans part of the
recognition signal for degradation? As
HRD1 is an E3 ubiquitin ligase, is ubiquiti-
nation required for degradation of EGFR
ligands?Finally, since theERADmachinery416 Developmental Cell 20, April 19, 2011 ª2is transcriptionally induced by the UPR
during periods of ER stress, is iRhom
expression similarly regulated by the
UPR? Given the conserved function of iR-
homs in regulating EGFR signaling in
mammals, the dissection of its physiolog-
ical significance and relevance to human
diseases, such as cancer, will be an area
of interest for future investigation.REFERENCES
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In this issue of Developmental Cell, Kitagawa et al. (2011a) and Song et al. (2011) show that the protein phos-
phatase PP2A regulates SAS-5 to control centriole duplication. Two paradigms are presented to explain how
PP2A regulates SAS-5.The intricate beauty of the centriole, with
its cartwheel architecture and 9-fold radial
symmetry, has awed and intrigued cell
biologists for decades since electron
micrographs first revealed its elegance in
reports published in the 1950s. While
much remains to be discovered regarding
the biogenesis of the elaborate centriole,
the key proteins involved in its assembly
were discovered in C. elegans in the
last 10 years. How these players are
regulated to execute accurate centriole
assembly is poorly understood. In a pair
of papers that appear in this issue of Dev
Cell from the Go¨nczy and O’Connell
labs, the serine/threonine protein phos-
phatase 2A (PP2A) is shown to regulate
an early essential component of centriole
biogenesis, SAS-5 (Kitagawa et al.,
2011a; Song et al., 2011). While both
reports demonstrate a role for PP2A
in regulating SAS-5 recruitment to
nascent centrioles, their results point to
two different models for how it is ac-
complished: in one scenario, phosphory-lation inhibits SAS-5 targeting to centri-
oles, and, in the other, phosphorylation
promotes SAS-5 destruction. Either way,
these reports establish that PP2A acti-
vates centriole duplication by promoting
SAS-5/SAS-6 incorporation at early
centrioles.
Prior genetic screens in C. elegans
revealed remarkably few proteins involved
in centriole replication. These core factors,
zygote defective-1 (ZYG-1), spindle defec-
tive-2 (SPD-2), and spindle assembly
abnormal -4, -5 and -6 (SAS-4, -5 and -6)
are mostly conserved in vertebrates
(Azimzadeh and Marshall, 2010). The
hierarchical relationship among these
factors in centriole assembly is shown
schematically in Figure 1. SPD-2, SAS-5,
SAS-6, and SAS-4 are coiled-coil proteins
with no discernable enzymatic activities.
ZYG-1, on the other hand, is a kinase
that phosphorylates SAS-6 to regulate
its recruitment to centrioles (Kitagawa
et al., 2009). SAS-6 is required for the
earliest steps of centriole assembly, es-tablishing the 9-fold symmetry by contrib-
uting to assembly of the cartwheel in some
organisms or to the central tube in
C. elegans (Azimzadeh and Marshall,
2010; Kitagawa et al., 2011b; van
Breugel et al., 2011). SAS-5 and SAS-6
are direct binding partners and are code-
pendent for localization to centrioles
(Leidel et al., 2005). But SAS-5 is more
dynamic, shuttling between the cyto-
plasm and centrioles, while SAS-6 is
retained at centrioles (Delattre et al.,
2004; Leidel et al., 2005). These dynamics
suggest that SAS-5 chaperones SAS-6 to
the emerging centriole, where SAS-6
contributes directly to the construction of
centriole architecture. Since PP2A
is required for SAS-6 localization in
C. elegans embryos and in human
cells (Kitagawa et al., 2011a; Song et al.,
2011), dephosphorylation of SAS-5 by
PP2Aappears to be a conservedmechan-
ism for centriole replication control.
PP2A is a highly conserved phos-
phatase that regulates a wide host of
